following

Wi-Charge Adds CMO and VP of People to Executive Team Following Series C FundingWi-Charge Adds CMO and VP of People to Executive Team Following Series C Funding

Wi-Charge Adds CMO and VP of People to Executive Team Following Series C Funding

Strategic Hires Underscore Momentum as Company Expands Global Commercialization of Long-Range Wireless Power TEL AVIV, Israel, Aug. 7, 2025 /PRNewswire/…

2 weeks ago
NordValor Launches Advanced AI Trading Engine Following Global Recognition as the Platform of Choice for Professional TradersNordValor Launches Advanced AI Trading Engine Following Global Recognition as the Platform of Choice for Professional Traders

NordValor Launches Advanced AI Trading Engine Following Global Recognition as the Platform of Choice for Professional Traders

London UK, July 31, 2025 (GLOBE NEWSWIRE) -- NordValor reviews are in the spotlight as the company announces the launch…

3 weeks ago
Treehouse Launches TREE Token Across Binance, OKX, Coinbase, and Top Exchanges Following Token Generation EventTreehouse Launches TREE Token Across Binance, OKX, Coinbase, and Top Exchanges Following Token Generation Event

Treehouse Launches TREE Token Across Binance, OKX, Coinbase, and Top Exchanges Following Token Generation Event

With listings on prominent CEXs and DEXs, Treehouse, the Decentralized Fixed Income Layer, activates TREE's first utility via Pre-Deposit Vaults,…

3 weeks ago
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination ChallengeEgg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and…

3 weeks ago
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) AgonistNxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 04, 2025 03:00 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…

2 months ago
Breakthrough GameChange Solar Terrain Following System Dramatically Reduces GradingBreakthrough GameChange Solar Terrain Following System Dramatically Reduces Grading

Breakthrough GameChange Solar Terrain Following System Dramatically Reduces Grading

--Genius Tracker TF™ now accommodates up to 1.7° post-to-post, enabling the industry's lowest grading requirement on challenging terrain-- NORWALK, Conn., July…

2 months ago
Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast EventFlower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event

Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event

Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and business growth. Attendees engage in…

2 months ago
CROSSJECT announces a successful capital increase of 5.7 million following full exercise of the extension clauseCROSSJECT announces a successful capital increase of 5.7 million following full exercise of the extension clause

CROSSJECT announces a successful capital increase of 5.7 million following full exercise of the extension clause

Press release CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause Transaction raised…

2 months ago
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial ResultsPolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

June 16, 2025 19:20 ET  | Source: PolyPid Ltd. The Company Anticipates that with this Additional Funding, PolyPid’s Runway would…

2 months ago
Consumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory MembershipConsumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory Membership

Consumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory Membership

NEW DELHI, June 6, 2025 /PRNewswire/ -- The World Health Organization (WHO) is facing intense scrutiny following the approval of…

3 months ago